Results 261 to 270 of about 809,322 (319)
Some of the next articles are maybe not open access.
Current Oncology Reports, 2001
Leukemia is susceptible to immune-mediated therapies such as allogeneic stem-cell transplantation, donor lymphocyte infusion, and interferon. The clinical effectiveness of these immune-based modalities has encouraged interest in vaccine therapies for leukemia.
J N, Kochenderfer, J J, Molldrem
openaire +2 more sources
Leukemia is susceptible to immune-mediated therapies such as allogeneic stem-cell transplantation, donor lymphocyte infusion, and interferon. The clinical effectiveness of these immune-based modalities has encouraged interest in vaccine therapies for leukemia.
J N, Kochenderfer, J J, Molldrem
openaire +2 more sources
Dermatologic Clinics, 1994
Leukemia cutis is an uncommon manifestation of leukemia that is strongly associated with the presence of extramedullary disease at other sites. Patients usually present with leukemia cutis concomitantly with systemic leukemia or after leukemia has been diagnosed.
K V, Ratnam, C J, Khor, W P, Su
openaire +2 more sources
Leukemia cutis is an uncommon manifestation of leukemia that is strongly associated with the presence of extramedullary disease at other sites. Patients usually present with leukemia cutis concomitantly with systemic leukemia or after leukemia has been diagnosed.
K V, Ratnam, C J, Khor, W P, Su
openaire +2 more sources
Current Treatment Options in Oncology, 2005
Prolymphocytic leukemia is a rare chronic lymphoproliferative disorder that includes two subtypes, B cell and T cell, each with its own distinct clinical, laboratory and pathological features. T-cell prolymphocytic leukemia has an aggressive course with short median survival and poor response to chemotherapy.
Ahmed, Absi, Eric, Hsi, Matt, Kalaycio
openaire +2 more sources
Prolymphocytic leukemia is a rare chronic lymphoproliferative disorder that includes two subtypes, B cell and T cell, each with its own distinct clinical, laboratory and pathological features. T-cell prolymphocytic leukemia has an aggressive course with short median survival and poor response to chemotherapy.
Ahmed, Absi, Eric, Hsi, Matt, Kalaycio
openaire +2 more sources
“Atypical” Leukemias: Preleukemia, Smoldering Leukemia and Hypoplastic Leukemia
1984The term “atypical leukemia” covers a wide range of heterogeneous disorders whose classification has hitherto been controversial. This controversy has arisen from the use of different criteria for the definition of the various entities. The application of morphological criteria has led to the separation of conditions without recognizable leukemic ...
D, Hoelzer, A, Ganser, H, Heimpel
openaire +2 more sources
Seminars in Oncology, 2006
T and B subtypes of prolymphocytic leukemias (PLLs) are rare, highly aggressive lymphoid malignancies with characteristic morphologic, immunophenotypical, cytogenetic, and molecular features. Recent studies have highlighted the role of specific oncogenes such as TCL1, MTCP-1, and ATM in the case of T-cell and p53 mutations in the case of B-cell PLLs ...
Krishnan, B, Matutes, E, Dearden, C
openaire +3 more sources
T and B subtypes of prolymphocytic leukemias (PLLs) are rare, highly aggressive lymphoid malignancies with characteristic morphologic, immunophenotypical, cytogenetic, and molecular features. Recent studies have highlighted the role of specific oncogenes such as TCL1, MTCP-1, and ATM in the case of T-cell and p53 mutations in the case of B-cell PLLs ...
Krishnan, B, Matutes, E, Dearden, C
openaire +3 more sources
Clinics in Perinatology, 2021
Neonates are at risk for 3 major forms of leukemia in the first year of life: acute leukemia, juvenile myelomonocytic leukemia, and transient abnormal myelopoiesis associated with Down syndrome. These disorders are rare but generate interest due to aggressive clinical presentation, suboptimal response to current therapies, and fascinating biology. Each
openaire +2 more sources
Neonates are at risk for 3 major forms of leukemia in the first year of life: acute leukemia, juvenile myelomonocytic leukemia, and transient abnormal myelopoiesis associated with Down syndrome. These disorders are rare but generate interest due to aggressive clinical presentation, suboptimal response to current therapies, and fascinating biology. Each
openaire +2 more sources
Pediatrics, 1970
The paper by Dr. Finklestein and others,1 leaves one with the impression that testicular involvement in acute leukemia, an almost general finding at post mortem, is an uncommon clinical problem. We wonder whether lack of awareness might not be responsible for this, as our own experience suggests.
F, Leef, G, Kende, B, Ramot
openaire +2 more sources
The paper by Dr. Finklestein and others,1 leaves one with the impression that testicular involvement in acute leukemia, an almost general finding at post mortem, is an uncommon clinical problem. We wonder whether lack of awareness might not be responsible for this, as our own experience suggests.
F, Leef, G, Kende, B, Ramot
openaire +2 more sources
Hematology/Oncology Clinics of North America, 1990
PLL is an unusual clinical and morphologic variant of CLL which, in the more common B cell version, represents malignant transformation of a B lymphocyte at an intermediate stage of development. The immunophenotype of PLL cells, characterized by heavy cell surface staining for IgM and/or IgD and loss of mouse red blood cell receptors, suggests ...
openaire +2 more sources
PLL is an unusual clinical and morphologic variant of CLL which, in the more common B cell version, represents malignant transformation of a B lymphocyte at an intermediate stage of development. The immunophenotype of PLL cells, characterized by heavy cell surface staining for IgM and/or IgD and loss of mouse red blood cell receptors, suggests ...
openaire +2 more sources
Blood, 1951
Abstract Four new cases of congenital leukemia reported here may be added to the 14 acceptable cases in the literature. In all except 1 of these cases cells of the granulocytic series were involved; males predominated over females in a ratio of more than 2 to 1.
W G, BERNHARD, I, GORE, R A, KILBY
openaire +2 more sources
Abstract Four new cases of congenital leukemia reported here may be added to the 14 acceptable cases in the literature. In all except 1 of these cases cells of the granulocytic series were involved; males predominated over females in a ratio of more than 2 to 1.
W G, BERNHARD, I, GORE, R A, KILBY
openaire +2 more sources
Critical Care Nursing Clinics of North America, 2013
The chronic leukemias include chronic myeloid leukemia (CML) and chronic lymphocytic leukemia (CLL). CML is a clonal myeloproliferative hematopoietic stem-cell disorder, and CLL is a monoclonal B-cell disorder. CML is Philadelphia chromosome positive. There are 3 phases of CML: the chronic phase, the accelerated phase, and the blast phase.
Edythe M Lyn, Greenberg +1 more
openaire +2 more sources
The chronic leukemias include chronic myeloid leukemia (CML) and chronic lymphocytic leukemia (CLL). CML is a clonal myeloproliferative hematopoietic stem-cell disorder, and CLL is a monoclonal B-cell disorder. CML is Philadelphia chromosome positive. There are 3 phases of CML: the chronic phase, the accelerated phase, and the blast phase.
Edythe M Lyn, Greenberg +1 more
openaire +2 more sources